
The pharma industry is growing significantly due to consistent research and development efforts, increasing demand for novel drugs, rising healthcare spending, and an aging population.
Therefore, investors could consider buying fundamentally robust pharma stocks Bristol-Myers Squibb Company (BMY), Johnson & Johnson (JNJ), Novartis AG (NVS), and Merck & Co., Inc. (MRK) now.